The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 7.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,213 shares of the medical device company’s stock after purchasing an additional 429 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Cooper Companies were worth $686,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of COO. Innealta Capital LLC bought a new position in shares of Cooper Companies in the second quarter worth $25,000. Ashton Thomas Securities LLC bought a new position in Cooper Companies in the 3rd quarter valued at about $25,000. Covestor Ltd increased its stake in Cooper Companies by 305.9% during the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after buying an additional 208 shares during the period. Crewe Advisors LLC increased its stake in Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after buying an additional 252 shares during the period. Finally, Tortoise Investment Management LLC raised its position in shares of Cooper Companies by 75.4% during the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after buying an additional 169 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Cooper Companies stock opened at $99.63 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $82.21 and a fifty-two week high of $112.38. The firm’s 50 day simple moving average is $106.83 and its 200-day simple moving average is $98.00. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The company has a market cap of $19.84 billion, a P/E ratio of 55.50, a price-to-earnings-growth ratio of 2.20 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same period in the previous year, the company posted $0.84 EPS. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Activity

In related news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. The trade was a 72.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. This represents a 78.94 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Robert W. Baird raised their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. Piper Sandler boosted their price objective on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. StockNews.com upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Thursday. Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Morgan Stanley raised their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.